About Accretion Therapeutics
Accretion Therapeutics is a private company based in Lincolnshire, Illinois, incorporated in 2026 in Delaware. It has reported $750,000 raised in one offering on Form D since February 2026.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Feb 17, 2026 | $750,000of $1.0M target | 1 | $750K | Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Accretion Therapeutics's Form D filed Feb 17, 2026.
DH
David Holecek
President and director